Status:
NOT_YET_RECRUITING
A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.
Lead Sponsor:
Equipmed USA LLC
Conditions:
Acne
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.
Eligibility Criteria
Inclusion
- Female subjects aged between 18-45 years (both ages inclusive)
- Fitzpatrick skin phototype I to VI.
- Subjects having IGA score of 2 and 3.
- Subjects who have not received any kind of treatment for acne 1 month before the start of the study.
- Subject free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, or any other skin conditions on the face.
- Subjects who agree not to use any other product/treatment/home remedy/ except the provided products on their face during the study period
Exclusion
- Subjects with known skin condition that may impact the assessment.
- Subjects with active Herpes labialis infection.
- Subjects known to have bleeding and clotting disorders (self-declared).
- Subjects known to have connective tissue disorders.
- Subjects with any other signs of significant local irritation or skin disease.
- Subjects currently taking any medication, which the investigator believes may influence the interpretation of the data.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06602284
Start Date
October 1 2024
End Date
March 1 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Wellness Dermatology
Birmingham, Alabama, United States, 35209